Fusion event
HBV-chr12 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CGTCGCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGG| |CATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTG
End
63552086/63158306 (Hg38)
Nearest miRNA
hsa-let-7i/Upstream/554537; hsa-mir-10527/Downstream/665357;
Upstream sequence
AAGAGGTTTGATCCATTGGATTGCAACCTCAATGTACATGAGAAAGTTTCTAAGATTAAATTTCTCTGAATATATTTAAAGTATGGACACGAAATGGAAT
Downstream sequence
AGGCTTGAAATATTTAGGGCTTTACCTCAGTGTTCCTGAACAGACTTTTACGTGGAAATGTTCTTTGATTACCTGGTAAGTCAACAGGAAGAAATAACAA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.